信息搜索
信息关键字:医药
 

共有1602条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81]

·2023年中期医药行业投资策略:做新周期的朋友2023-6-13 18:13:40
·恩威医药:签订《药品上市许可持有人(MAH)转让合同》2023-6-13 18:05:13
·复星医药等3家中国药企跻身全球研发管线规模Top252023-6-13 17:52:30
·景峰医药(000908)6月13日主力资金净卖出316.43万元2023-6-13 16:12:22
·泓博医药(301230)6月12日主力资金净买入159.97万元2023-6-13 9:29:08
·医药生物投融资周报:西山科技上市,纳微收仪器2023-6-13 8:21:44
·医药生物行业周报:血制品行业利好频出,重点关注2023-6-12 21:24:19
·医药生物行业周报:核药应用场景广泛,关注百亿美元蓝海市场2023-6-12 17:52:10
·医药行业周报:医保谈判启动,关注创新主线2023-6-12 17:22:26
·医药生物行业周报:医保目录调整在即,多款品种有望入选2023-6-12 16:19:26
·博济医药(300404)6月12日主力资金净卖出604.42万元2023-6-12 16:02:35
·迪哲医药:舒沃替尼于舒沃替尼获开展全球III期多中心临床试验2023-6-12 15:50:11
·医药生物行业周报:医药进入复苏验证期和缺乏景气行业的迷茫期,自下而上逻辑更为重要2023-6-12 12:31:45
·医药生物行业周报:关注中药配方颗粒和血制品的长期投资机会2023-6-12 11:28:53
·医药生物行业跟踪周报:抵御市场风险战略性配置血制品,建议关注卫光生物、天坛生物、华兰生物、博雅生物等2023-6-12 10:59:18
·华润医药所属公司限定毓婷售价被罚1264万旗下5家上市公司3年罚赔款超8000万2023-6-12 9:47:33
·百洋医药携手莱博瑞辰就全球首个治疗骨坏死创新药达成商业化战略合作2023-6-12 9:13:49
·医药生物周跟踪:医保又调整,破局靠创新2023-6-11 18:34:18
·智翔金泰:科创板再添创新驱动型生物医药新势力2023-6-11 10:39:24
·股票行情快报:南京医药(600713)6月9日主力资金净卖出311.69万元2023-6-10 0:19:52

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81]